These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17036045)

  • 1. An extended consensus motif enhances the specificity of substrate modification by SUMO.
    Yang SH; Galanis A; Witty J; Sharrocks AD
    EMBO J; 2006 Nov; 25(21):5083-93. PubMed ID: 17036045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.
    Hsieh YL; Kuo HY; Chang CC; Naik MT; Liao PH; Ho CC; Huang TC; Jeng JC; Hsu PH; Tsai MD; Huang TH; Shih HM
    EMBO J; 2013 Mar; 32(6):791-804. PubMed ID: 23395904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMO: getting it on.
    Anckar J; Sistonen L
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of K65 acetylation-induced attenuation of Ubc9 and the NDSM interaction.
    Naik MT; Kang M; Ho CC; Liao PH; Hsieh YL; Naik NM; Wang SH; Chang I; Shih HM; Huang TH
    Sci Rep; 2017 Dec; 7(1):17391. PubMed ID: 29234076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
    Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
    J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMO modification of Akt regulates global SUMOylation and substrate SUMOylation specificity through Akt phosphorylation of Ubc9 and SUMO1.
    Lin CH; Liu SY; Lee EH
    Oncogene; 2016 Feb; 35(5):595-607. PubMed ID: 25867063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription regulation of nuclear receptor PXR: Role of SUMO-1 modification and NDSM in receptor function.
    Priyanka ; Kotiya D; Rana M; Subbarao N; Puri N; Tyagi RK
    Mol Cell Endocrinol; 2016 Jan; 420():194-207. PubMed ID: 26549688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation.
    Ji Z; Degerny C; Vintonenko N; Deheuninck J; Foveau B; Leroy C; Coll J; Tulasne D; Baert JL; Fafeur V
    Oncogene; 2007 Jan; 26(3):395-406. PubMed ID: 16862185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
    Subramanian L; Benson MD; Iñiguez-Lluhí JA
    J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
    Yunus AA; Lima CD
    Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-translational modification of POU domain transcription factor Oct-4 by SUMO-1.
    Zhang Z; Liao B; Xu M; Jin Y
    FASEB J; 2007 Oct; 21(12):3042-51. PubMed ID: 17496161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
    Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
    Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a novel posttranslational modification in neuronal nitric oxide synthase by small ubiquitin-related modifier-1.
    Watanabe M; Itoh K
    Biochim Biophys Acta; 2011 Jul; 1814(7):900-7. PubMed ID: 21545853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO Ubc9 enzyme as a viral target.
    Varadaraj A; Mattoscio D; Chiocca S
    IUBMB Life; 2014 Jan; 66(1):27-33. PubMed ID: 24395713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
    Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G
    Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions.
    Liu ST; Chang YL; Wang WM; Chung MH; Lin WS; Chou WY; Huang SM
    Int J Biochem Cell Biol; 2012 Mar; 44(3):547-55. PubMed ID: 22227369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO modification of the ubiquitin-conjugating enzyme E2-25K.
    Pichler A; Knipscheer P; Oberhofer E; van Dijk WJ; Körner R; Olsen JV; Jentsch S; Melchior F; Sixma TK
    Nat Struct Mol Biol; 2005 Mar; 12(3):264-9. PubMed ID: 15723079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO assay with peptide arrays on solid support: insights into SUMO target sites.
    Schwamborn K; Knipscheer P; van Dijk E; van Dijk WJ; Sixma TK; Meloen RH; Langedijk JP
    J Biochem; 2008 Jul; 144(1):39-49. PubMed ID: 18344540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small ubiquitin-like modifier (SUMO) conjugation impedes transcriptional silencing by the polycomb group repressor Sex Comb on Midleg.
    Smith M; Mallin DR; Simon JA; Courey AJ
    J Biol Chem; 2011 Apr; 286(13):11391-400. PubMed ID: 21278366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct functional modes of SUMOylation for retinoid X receptor alpha.
    Lee WP; Jena S; Rodriguez EP; O'Donovan SP; Wagner C; Jurutka PW; Thompson PD
    Biochem Biophys Res Commun; 2015 Aug; 464(1):195-200. PubMed ID: 26116533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.